OmniAb Corp (OABI): מחיר למכירות

סמל ולוגו של המותג OmniAb Inc. (OABI)

OmniAb, Inc. (OABI) possesses high software scalability, enabling the company to expand margins through partner payments. The enterprise value-to-revenue multiple reflects the business valuation trend, with the indicator fixed at 17.80. Development relies on ESG principles, reducing the use of reagents. However, geopolitical risks and sanctions could hinder the protection of intellectual property and access to international R&D budgets.

OABI OmniAb Inc.: יחס מחיר להכנסות בטווח 28.04.2023 - 16.11.2026

פילוחים אנליטיים של חברת OmniAb Inc (OABI)

- מחיר ותחזית קונצנזוס למחירים:
- נתוני שווי שוק בבורסה:
ניתוח כללי של החברה:OmniAb Corp OABI
מוצר עיקרי של OmniAb Corp

OmniAb, Inc. (OABI) utilizes unique bio-factories of genetically modified animals to accelerate the development of anti-cancer drugs, making the company's revenue a key value driver. By analyzing the company's price-to-sales ratio, an investor determines the extent of the premium paid for current sales: inflated values signal unjustified expectations, while low values indicate an undervalued asset or business stagnation.